(thirdQuint)Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers.

 OBJECTIVES: Primary - Compare the systemic exposure of sulindac tablets vs sulindac capsules in healthy volunteers.

 Secondary - Compare the terminal half-life and time of peak drug concentration of sulindac tablets vs sulindac capsules.

 OUTLINE: This is a randomized study.

 Participants are randomized to 1 of 2 treatment arms.

 - Arm I: Participants receive one sulindac capsule followed 7-10 days later by one sulindac tablet.

 - Arm II: Participants receive one sulindac tablet followed 7-10 days later by one sulindac capsule.

 Blood is collected periodically during treatment for pharmacokinetic studies.

 After completion of study therapy, participants are followed at 7-10 days.

 PROJECTED ACCRUAL: A total of 28 participants will be accrued for this study.

.

 Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers@highlight

RATIONALE: Giving healthy volunteers sulindac capsules or sulindac tablets may help doctors learn which form of the drug may be more effective in preventing cancer.

 PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in healthy volunteers.

